Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment

Lingling Lu, Takayoshi Mamiya, Takenao Koseki, Akihiro Mouri, Toshitaka Nabeshima

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Accumulating evidence supports the existence of an overlap in genetic susceptibility with schizophrenia. Translation of human genetic mutations into animals is one of the most important strategies to study the pathogenesis of schizophrenia, identify potential drug targets, and test new medicines for antipsychotic treatment. Recent discoveries of susceptibility genes for schizophrenia make the possibility to develop newer genetic mouse models based on the neurodevelopmental hypotheses of schizophrenia. Although it is not possible to mimic all schizophrenic symptoms by these animal models, the genetic mouse models based on the neurodevelopmental hypothesis are widely developed to reproduce several schizophrenia-like behavioral and biochemical changes in humans. In this mini review, we will discuss the neuropathological and behavioral manifestations of representative genetic mouse models for schizophrenia, associated with the hypothesis of abnormal neurodevelopment.

Original languageEnglish
Pages (from-to)1358-1363
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume34
Issue number9
DOIs
Publication statusPublished - 01-09-2011

Fingerprint

Genetic Models
Schizophrenia
Animal Models
Medical Genetics
Genetic Association Studies
Genetic Predisposition to Disease
Antipsychotic Agents
Mutation
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{28b1fe04c00a47e3ac704b4b72291eb6,
title = "Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment",
abstract = "Accumulating evidence supports the existence of an overlap in genetic susceptibility with schizophrenia. Translation of human genetic mutations into animals is one of the most important strategies to study the pathogenesis of schizophrenia, identify potential drug targets, and test new medicines for antipsychotic treatment. Recent discoveries of susceptibility genes for schizophrenia make the possibility to develop newer genetic mouse models based on the neurodevelopmental hypotheses of schizophrenia. Although it is not possible to mimic all schizophrenic symptoms by these animal models, the genetic mouse models based on the neurodevelopmental hypothesis are widely developed to reproduce several schizophrenia-like behavioral and biochemical changes in humans. In this mini review, we will discuss the neuropathological and behavioral manifestations of representative genetic mouse models for schizophrenia, associated with the hypothesis of abnormal neurodevelopment.",
author = "Lingling Lu and Takayoshi Mamiya and Takenao Koseki and Akihiro Mouri and Toshitaka Nabeshima",
year = "2011",
month = "9",
day = "1",
doi = "10.1248/bpb.34.1358",
language = "English",
volume = "34",
pages = "1358--1363",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "9",

}

Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment. / Lu, Lingling; Mamiya, Takayoshi; Koseki, Takenao; Mouri, Akihiro; Nabeshima, Toshitaka.

In: Biological and Pharmaceutical Bulletin, Vol. 34, No. 9, 01.09.2011, p. 1358-1363.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment

AU - Lu, Lingling

AU - Mamiya, Takayoshi

AU - Koseki, Takenao

AU - Mouri, Akihiro

AU - Nabeshima, Toshitaka

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Accumulating evidence supports the existence of an overlap in genetic susceptibility with schizophrenia. Translation of human genetic mutations into animals is one of the most important strategies to study the pathogenesis of schizophrenia, identify potential drug targets, and test new medicines for antipsychotic treatment. Recent discoveries of susceptibility genes for schizophrenia make the possibility to develop newer genetic mouse models based on the neurodevelopmental hypotheses of schizophrenia. Although it is not possible to mimic all schizophrenic symptoms by these animal models, the genetic mouse models based on the neurodevelopmental hypothesis are widely developed to reproduce several schizophrenia-like behavioral and biochemical changes in humans. In this mini review, we will discuss the neuropathological and behavioral manifestations of representative genetic mouse models for schizophrenia, associated with the hypothesis of abnormal neurodevelopment.

AB - Accumulating evidence supports the existence of an overlap in genetic susceptibility with schizophrenia. Translation of human genetic mutations into animals is one of the most important strategies to study the pathogenesis of schizophrenia, identify potential drug targets, and test new medicines for antipsychotic treatment. Recent discoveries of susceptibility genes for schizophrenia make the possibility to develop newer genetic mouse models based on the neurodevelopmental hypotheses of schizophrenia. Although it is not possible to mimic all schizophrenic symptoms by these animal models, the genetic mouse models based on the neurodevelopmental hypothesis are widely developed to reproduce several schizophrenia-like behavioral and biochemical changes in humans. In this mini review, we will discuss the neuropathological and behavioral manifestations of representative genetic mouse models for schizophrenia, associated with the hypothesis of abnormal neurodevelopment.

UR - http://www.scopus.com/inward/record.url?scp=80052501979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052501979&partnerID=8YFLogxK

U2 - 10.1248/bpb.34.1358

DO - 10.1248/bpb.34.1358

M3 - Review article

C2 - 21881217

AN - SCOPUS:80052501979

VL - 34

SP - 1358

EP - 1363

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 9

ER -